Medical device with Hyaluronic Acid, Magnesium Alginate, and Myrrh: intense and lasting relief against gastroesophageal reflux Starting from 2025, we have officially registered our Class IIa medical device for the treatment of severe gastroesophageal reflux disease (GERD) with the Ministry of Health and Prevention of the United Arab Emirates (UAE). Severe GERD: a significant impact…
Registration of Class IIa Medical Device for Gastroesophageal Reflux at the Department of Health in Hanoi, Vietnam The Department of Health in Hanoi, Vietnam officially registered our Class IIa medical device. Additionally, it’s important to note that the device holds an MDD certificate extension. The device is an oral emulsion composed of key actives: low…
Extension of MDD Certificate for Our Medical Devices for the Treatment of Gastroesophageal Reflux Disease (GERD) Based on Alginates The MDR regulation, effective from May 2017 and applicable from May 2021, governs medical devices in Europe. Deadline extensions allow the marketing of devices compliant with the Medical Devices Directive (MDD) until December 31, 2027, for…